MARKET

ASRT

ASRT

Assertio Therapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.120
-0.050
-4.27%
After Hours: 1.070 -0.05 -4.46% 19:10 01/24 EST
OPEN
1.180
PREV CLOSE
1.170
HIGH
1.220
LOW
1.110
VOLUME
1.25M
TURNOVER
--
52 WEEK HIGH
5.76
52 WEEK LOW
0.6829
MARKET CAP
90.36M
P/E (TTM)
-1.4644
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ASRT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ASRT News

  • Is ASSERTIO THERAPEUTICS, INC (ASRT) Outperforming Other Medical Stocks This Year?
  • Zacks.4d ago
  • Assertio (ASRT) Stock Sinks As Market Gains: What You Should Know
  • Zacks.01/15 22:45
  • ASRT or PCRX: Which Is the Better Value Stock Right Now?
  • Zacks.01/13 16:40
  • DDD, NVTA among premarket gainers
  • Seeking Alpha - Article.01/13 14:27

More

Industry

Pharmaceuticals
-1.84%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About ASRT

Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution), Xartemis XR and Zipsor (diclofenac potassium). Its NUCYNTA ER (tapentadol extended release tablets) is a product for the management of pain severe enough to require daily long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults, and its NUCYNTA (tapentadol) is a product for the management of moderate to severe acute pain in adults. Its Gralise (gabapentin) is a once-daily product for the management of postherpetic neuralgia (PHN). Its Cambia (diclofenac potassium for oral solution) is a product for the acute treatment of migraine attacks.
More

Webull offers Assertio Therapeutics Inc (ASRT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.